Adam D. Durbin
St. Jude Children's Research Hospital(US)Molecular Oncology (United States)(US)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Protein Degradation and Inhibitors, Sarcoma Diagnosis and Treatment, Histone Deacetylase Inhibitors Research, Ubiquitin and proteasome pathways
Most-Cited Works
- → An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element(2014)802 cited
- → Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism(2015)301 cited
- → Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry(2018)295 cited
- → MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification(2017)233 cited
- → Recurrent Focal Copy-Number Changes and Loss of Heterozygosity Implicate Two Noncoding RNAs and One Tumor Suppressor Gene at Chromosome 3q13.31 in Osteosarcoma(2010)172 cited
- → A first-generation pediatric cancer dependency map(2021)153 cited